Introduction
Magnetic nanoparticles (MNPs) or superparamagnetic iron oxide nanoparticles (SPIONs) are emerging as promising candidates for applications in biomedicine for drug delivery [1] [2] [3] , magnetic resonance imaging (MRI) [1, 3] , and hyperthermia-based therapy, in research projects encompassing cell mechanics, tumor progression dynamics, in vivo tracking of stem cells [4] [5] [6] , and in general molecular and cell biology for nucleic acid isolation and cell separation [7] . This is all due to their ultra-fine and tunable size, notable biocompatibility, and superparamagnetic behavior. Additionally, what is important for biomedical applications, the MNPs feature increased cell tropism, favorable biophysical properties, and low toxicity [2, 8, 9] .
Each of the above-mentioned applications requires that a specific set of physical, chemical, and biological properties be combined in a given sample of nanoparticles so that they will work as intended. Some of these properties are fundamental: They strictly predispose the particles to positive or negative behavior both in vitro and in vivo. These properties are the charge, the solution stability and zeta potential, and the coating of the nanoparticles. A good combination of these properties may satisfy a researcher in an in vitro study, but other properties should also be considered when in vivo applications are planned. For in vivo experiments, additional determinants of the quality of nanoparticles are their size, shape, modifications with targeting moieties, and degradation/excretion pathways.
This review is aimed at helping those involved in designing and synthesizing nanoparticles for biological and biomedical applications by addressing how each of the above-listed properties affect the performance or task suitability of MNPs.
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Summary
Magnetic and superparamagnetic iron oxide nanoparticles are emerging as promising candidates for various applications in biology and medicine, and especially in oncology. These applications, however, require that a specific set of physical, chemical, and biological properties be combined in a given sample of nanoparticles for them to act as intended. Some of these properties are fundamental: They strictly determine the nanoparticles' behavior both in vitro and in vivo. These properties are the charge, the solution stability and zeta potential, and the coating of the nanoparticles. A certain combination of these properties may satisfy a researcher in an in vitro study, but other properties should also be considered when in vivo applications are planned. For in vivo experiments, additional determinants of the quality of nanoparticles are their size, shape, modifications with targeting moieties, and degradation/excretion pathways. All these properties are in the focus of the present review.
Nanoparticle Charge
The outer surface of the lipid bilayer forming the cell membranes is negatively charged [10] , and membrane internalization (endocytosis) is charge dependent [10] . Proteins opsonizing circulating particles and thus promoting phagocytosis are dependent on the charge of the agent being opsonized [11] . Extracellular matrix components vary in charge and, consequently, their affinity to exogenous factors is charge dependent [11] . Thus, the charge of nanoparticles can be used to meet specific requirements of a study.
The surface charge (or electrophoretic mobility) of the nanoparticles should not be confused with the zeta potential. Inherently, depending on the synthesis components, iron oxide nanoparticles may be neutral, or they may be negatively or positively charged [12] . The above-mentioned biological determinants cause neutral nanoparticles to have a lower uptake speed as opposed to charged nanoparticles, and positive and negative nanoparticles, to differ in clearance speed and biodistribution [11, 12] . In the end, neutral and slightly negatively charged nanoparticles have an extended circulation period [11] .
The surface charge of the nanoparticles also greatly influences the efficiency of their internalization by endocytosis. For example, positively charged nanoparticles are selectively and efficiently internalized by clathrin-mediated endocytosis [10] . Exocytosis is also charge dependent. Although not shown for SPIONs, it is known that, in spite of the higher speed of endocytosis of positively charged nanoparticles, they accumulate on the vascular endothelium without subsequent penetration into the tissues or tumors, in contrast to their slightly anionic and anionic counterparts [11] .
On the other hand, positively charged nanoparticles that are based on «proton sponge» chemistry evade lysosomes by disrupting their functioning, causing their swelling and rupture [13] . Although beneficial for re-distribution in the tissue, the proton sponge property has apparent drawbacks.
It is considered that the optimal surface charge of nanoparticles for biomedical applications, including tumor targeting, should be close to neutral or slightly negative [11] ; however, one should also bear in mind that the surface charge affects the zeta potential and that, in turn, the zeta potential determines the solution stability of the nanoparticles.
Solution Stability and Zeta Potential
Magnetic iron oxide nanoparticles with a bare surface tend to agglomerate because of strong magnetic attractions between the particles; thus, stabilizers such as carboxylates, inorganic compounds, and polymeric compounds are usually used to enhance the stability of the nanoparticles in suspension [14] . However, these stabilizers are often incompatible with biomedical applications. In this case and sense, solution stability is dictated by the zeta (ζ-)potential. The zeta potential is a bulk property specified by several parameters: the charge of the nanoparticles and the ionic content and strength of the solution [2] . Suspensions of neutral or slightly charged nanoparticles (i.e. the zeta potential is within the range of -25 to +25 mV) are not stable and tend to coagulate or flocculate [11] ; thus, the zeta potential in a carrier biological fluid should be below -25 mV or above +25 mV for the nanoparticles to be practically applicable.
In addition to the above data, it is notable that effective small (< 100 nm) nanoparticles for MRI and tissue penetration have a negative net charge, while effective large nanoparticles (> 100 nm) have a positive net charge. Generally, the question of tissue penetration and accumulation efficacy as a function of the zeta-potential or net charge of the nanoparticles remains open [15] .
In order to modify the zeta potential of a nanoparticle formulation, given their inherent properties are unfavorable, one can use numerous coatings. However, these coatings will have strong biological effects.
Coating
The combination of synthetic, inorganic, and biogenic polymers with inorganic nanoparticles is the basis for the development of theranostic systems, i.e. the nanosystems simultaneously used for both therapy and diagnostics [11, 16, 17] . This is possible mostly on account of the coatings, which during the respective applications will help keep the particles finely dispersed and reduce nonspecific protein adsorption and clearance by macrophages [8] . There are many different coatings for magnetite particles -and this is probably the most important and complex variable in the design of application-specific SPIONs. The most widely used coating variants are polyethylene glycol (PEG), dextran, chitosan, silica, starch, dimercaptosuccinic acid (DMSA), poly(L-lactic acid), citrate, oleate or oleic acid, and their combinations and derivatives [18] .
The type of coating determines the circulation half-life of the nanoparticles. The key role in the process of recognition and elimination of intravenously injected nanoparticles, which determines their circulation time, is played by the reticuloendothelial system (RES) [11] . The coatings differ in the characteristics of their interactions with the RES cells.
PEG is a biocompatible synthetic polymer [19] ; it is often used, alone or in combination with other building blocks, to minimize unwanted interactions of the nanoparticles with plasma proteins and macrophages. The circulation time of the PEGylated nanoparticles is determined by the molecular weight of the used PEG, the PEGylation density, and the co-polymer type [15] . It is critical to take note of the fact that a high surface density of PEG may hinder the interaction of the nanoparticles with the target cell surface. Another obstacle of PEGylation is the generation of PEG-specific immunoglobulin M (IgM) and IgG antibodies. Anti-PEG antibodies cause accelerated blood clearance of PEG-coated nanomedicines [11, 20] . Moreover, it has been reported several times that anti-PEG antibodies are also present in treatment-naïve people [19, 21] . In addition to diminishing the efficacy of the PEGylated nanoparticles, this immune reaction also confers significant side-effects or risks [19] . The risks and mechanisms of the side-effects have been described elsewhere [22] . These facts emphasize the need to test patients for anti-PEG antibodies before administering PEGylated nanosystems.
Dextran is a biopolymer of bacterial origin [23] . It is biocompatible [24] , reduces the cytotoxicity of SPIONs [25] and is easy to functionalize [24] . Dextran-coated SPIONs are already widely used in the clinic as MRI contrast agents [8, 26, 27] . Following intravenous injection, dextran-coated SPIONs become extensively coated by plasma proteins and are rapidly cleared from the circulation by resident macrophages, with a half-life of 1-3 h in humans [27] . This gives the dextran-coated SPIONs an advantage in MRI of the liver and in diagnosing cancer if macrophages are involved [28] . In all other cases, however, interactions of nanoparticles with macrophages are unwanted.
Chitosan, an abundant naturally occurring polysaccharide, is often used in combination with MNPs, including SPIONs [16] . Due to their biocompatibility, chitosan-coated iron oxide nanoparticles (Fe 3 O 4 -NPs) have been widely studied for biomedical applications, such as in MRI, as magnetic hyperthermia agents, and for drug delivery in cancer studies. The combination of Fe 3 O 4 -NPs with chitosan is one of the hot topics for the development of theranostic systems [16] .
Silica (SiO 2 ) is a naturally occurring mineral, and it is also synthesized for specific applications. Silica-coated iron oxide nanoparticles are now being actively tested for their cytotoxicity [29] and internalization capability [30] [31] [32] . Data collected until now suggest silica-coated nanoparticles as very promising agents for drug delivery [17, 31] , MRI [33] , and other biomedical applications [33, 34] . Yet, although this type of nanoparticle coating is currently being actively studied, there are still no comprehensive data on its biological effects and hazards.
Starch is a polysaccharide built of α-glucose. At the moment of preparation of this review, there was a lack of data characterizing the effects of this type of coating on the human organism. Starch itself is a non-toxic biodegradable substance [35] ; yet, it can be immunogenic. It was shown in animal studies that starch may cause allergy, peritonitis, and granuloma [36] . The circulation time of starch-coated iron oxide nanoparticles in humans is unknown. In pigs, these nanoparticles circulate for up to 150 min; data for rodents are also available [15] .
Other coatings, namely DMSA [37, 38] , poly(L-lactic acid) [39] , citrate [40] , oleic acid [41] , or oleate [42] , and their derivatives, were only used in a few studies, and their biological effects and properties are poorly studied.
The use of a coating of whatever type appears to be inevitable for stabilizing nanoparticles and prolonging their circulation time. However, coatings also increase the size of the nanoparticles, and the size is one of the most important parameters for biomedical applications of nanosystems.
Size
SPIONs are divided into 3 main categories based on their hydrodynamic diameter: oral SPIONs of 300-3.5 mm, standard SPIONs (SSPIO) of 50-150 nm, and ultra-small SPIONs (USPIO) of < 50 nm. SPIONs that are 10-100 nm in size are considered optimal for intravenous administration, whereas particles larger than 200 nm and smaller than 10 nm are sequestered by the spleen or removed through renal clearance, respectively [3, 11, 43, 44 ]. An additional feature of nanoparticles of less than 34 nm is that they travel from the lungs to the lymph nodes [3] .
There are several biological factors that determine the appropriate size of the nanoparticles to be chosen for a given application. Firstly, nanoparticles accumulate non-specifically in areas with increased vascular permeability, such as tumors and inflamed tissues [3] . Secondly, other vasculature features of the target tissue should be considered, and the diameter of fenestrae is the primary property to be taken into account. Normal capillaries are categorized as non-fenestrated, fenestrated, and sinusoidal. Fenestrated capillaries have fenestrae of 80 nm in diameter while sinusoidal capillaries have wider openings between the cells [45] . The majority of tumor vessels have an average pore size ranging from 380 to 780 nm [3] . Thirdly, tumors have large vascular fenestrae; however, the larger the nanoparticles, the harder they will travel through the extracellular space [3] and the more dependent on transcytosis their effects will become [46] .
In clinical settings, both large and small nanoparticles are used according to the tasks. Generally, small nanoparticles are coated in order to prevent their fast clearance. Large nanoparticles are used in various applications, and sometimes fast RES uptake is advantageous [28] . In contrast, when RES-mediated clearance is a limitation, a simple solution is to use dextran sulfate 500 (DSO 4 500), a temporarily acting Kupffer cell blocking agent [28] .
Although the size of the nanoparticles is probably the most important determinant of their cellular uptake rate [47] , it is not the sole determinant.
Shape
The next important 'passive' property of nanomedicines that affects the cellular uptake as well as extravasation and tumor accumulation is the shape of the particles. Firstly, the shape of the nanoparticles influences their phagocytosis by macrophages. Elongated nanoparticles with high length-to-diameter ratios have a smaller chance to be internalized by phagocytic cells compared to their spherical counterparts. In addition to prolonged circulation, the high aspect ratio and the large surface area of the elongated nanoparticles contribute to their superior tumor deposition: Changes in blood flow direction in tortuous tumor vessels cause tumbling and collision of the elongated nanoparticles with the vessel walls [11] .
Importantly, although showing increased binding to the tumor endothelium, elongated nanoparticles often demonstrate poor extravasation [11] . As the extravasation dynamics is still hard to predict, this property should be studied for each sample of nanoparticles being developed.
Passive targeting characteristics of nanoparticles, like shape and size, are not as effective as is required in the clinical setting. Thus, active functional targeting may have to be employed.
Functional Targeting
Specific accumulation in the tissue of interest is a strict requirement for nanoparticles in medicine. One possible method to achieve this is to use active targeting. A ligand or an antibody, or an aptamer or a molecularly imprinted polymer, should not detach from the nanosystem and must bind to the target molecule with high avidity and affinity [3] . To date, affinity ligands have been used to deliver SPIONs to a range of different targets, including tumor cells, tumor vasculature, and atherosclerotic plaques [11, 48] . In addition to ligands that have been successfully used for these purposes [49, 50] , antibodies [51] [52] [53] and aptamers [54, 55] are also routinely and successfully used.
Usually, this approach aims for strong binding of nanotherapeutics to target cells, prolonged retention in the target site, and/or receptor-mediated internalization [11] . Notwithstanding these expectations, it should be noted that targeting mainly prevents the washout of the smaller nanoparticles from the extravascular compartment, especially in tumor regions with slow flow [11] .
One serious pitfall in using functionalization is that the size and the charge of the nanoparticles will be changed, with all the consequences described above. Functionalization of nanoparticles with a ligand can also limit their penetration into the tumor because of the so-called 'binding site barrier' phenomenon: Penetration of ligand-bearing nanoparticles into the target tissue can often be limited by their own binding to those target cells that are in close proximity to blood vessels [11] .
When, eventually, the nanoparticles are delivered (although to date delivery is never 100% specific), the great question is how they will behave in the cells and tissues over long periods of time.
Biocompatibility, Degradation, and Excretion of Nanoparticles
SPION internalization is time and concentration dependent [9] , and the nanoparticles further undergo degradation or exocytosis [9] .
After short incubation times as, e.g., 30 min or 1 h, the SPIONs are mainly located in the secondary lysosomes. However, after longer incubation periods of 3-24 h, the SPIONs appear to be bound to the luminal membrane of organelles > 500 nm in size, similar to multivesicular bodies and which are located in the peripheral cytoplasmic regions and away from the nucleus [9] . As for the further intracellular destiny of SPIONs, Arbab et al. [56] investigated the metabolic fate and biological effects of poly-L-lysineand protamine sulfate-modified dextran-coated SPIONs (ferumoxides) on HeLa cells and human mesenchymal stem cells (hMSCs). They found that the nanoparticles could not be detected after 5-8 passages in the rapidly dividing HeLa cells, but endosomal iron nanoparticles could still be detected after 7 weeks in the slowly dividing hMSCs [9] . The dilution effect decreases the nanoparticle content in the cells, but it is not solely responsible for the cellular elimination of iron oxide nanoparticles. Iron can be released from the cells and become available for iron metabolic pathways, and this was seen in several studies [9, 56] .
Conclusions
The physicochemical properties of MNPs dramatically affect their behavior in vitro and in vivo. Fortunately, most of the effects are predictable, and the nanoparticles can be rationally designed to meet the requirements of a given application. Some questions, however, still remain unanswered, and among these, the properties of some coating variants are of great importance. There is also a great need for novel data on the effects of the net charge of nanoparticles on their circulation half-life and for a computational approach towards the calculation of the effects of ligand attachment on the zeta potential and the size of nanoparticles. Advancements in these fields will allow precise tuning of the properties of nanoparticles for a given application type, timeframe of diagnosis, and therapy.
